Company Profile 

About Us

A rising captain of the pharmaceutical industry, Sagmel, Inc. specializes in the development, manufacture, and marketing of leading OTC drugs and nutritional supplements. Our comprehensive product line represents all major categories and dosage forms and includes many of the best-known consumer brands throughout Europe and Asia. Sagmel is a privately owned company with major branch offices in seven countries including the U.S., which is home to its board of directors. Our products are manufactured in the U.S. in strict accordance with all pharmaceutical cGMPs and have captured a significant market share throughout our distribution area. With a corporate growth rate ranging between 25 and 40 percent since 1998, Sagmel continues to provide the highest quality OTC drugs and nutritional supplements to more consumers every year.  

  Mission Statement 

     Sagmel will become the largest, most trusted provider of consumer brand OTC drugs and nutritional supplements in both domestic and international markets. In addition, we will endeavor to enrich the quality of life for consumers everywhere through the development and manufacturing of superior health products. 

1992 -     Sagmel incorporated.
1993 -    Sagmel creates and introduces its umbrella brand, Health Life.
1996 -      First foreign branch of Sagmel opens.
1997 -    Sagmel catches the attention of industry giant Perrigo, who purchases

              the company.
2000 -     A change in ownership occurs again as Sagmel is purchased from 

              Perrigo.
              The company expands its manufacturing base significantly throughout

              the U.S.
2001 -   Sales and market share of Sagmel products increase tremendously,

              fueling extension into new markets. Operating under the ownership of different 

              private entities, the company experiences substantial growth.

Future

     Sagmel’s swift expansion continues unchecked, with a projected annual corporate growth of 25% for the next 5 years. Our brands are positioned strategically to increase their already substantial market shares worldwide.
     Furthermore, as one of the few U.S.-based companies actively procuring European GMP certifications, Sagmel is poised to broaden its market substantially throughout Europe and the Far East. The company has also partnered with various biotechnology firms to develop new, patented products that will amplify our brand presence. 

Facilities 

     Sagmel products are manufactured at 13 FDA-inspected locations spanning six U.S. States: New York, New Jersey, Connecticut, Pennsylvania, Michigan, and Wisconsin. Our contract manufacturers rank among the most respected in the U.S.; together, they provide products to hundreds of trusted mass market retailers, chain drug stores, wholesalers, and distributors. All of Sagmel’s manufacturers operate state-of-the art facilities that feature ultramodern manufacturing, packaging, and laboratory equipment. 

Manufacturing & Packaging 

Assurance 

     Sagmel is dedicated to providing the most trusted consumer brand OTC drugs and nutritional supplements in the world. Pharmaceutical quality assurance is of the utmost importance to our mission to enhance the health and lives of consumers everywhere.
     Sagmel’s partners uniformly operate under rigorous Quality Assurance and Quality Control programs to guarantee our products are of unsurpassed quality. All production processes, beginning with the receipt of raw materials and continuing through manufacturing and packaging, are conducted in strict accordance with meticulous Standard Operating Procedures. Highly-trained Quality Assurance and Quality Control personnel analyze Sagmel products in each stage of production to assure all standards are met or exceeded.

R & D
     Seeking to improve consumers’ health worldwide, Sagmel continues to invest heavily in pharmaceutical Research and Development. Throughout its history, our company has funded extensive clinical research and comparison studies. This research, cited in various clinical journals and textbooks, has consistently confirmed the superiority of Sagmel products.
Today, Sagmel has joined with leaders in the biotechnology industry to develop new, patented health products that will further augment its position in the world market. 

Marketing

     Sagmel products command a high percentage of the market share in the countries in which they are distributed. For example, our suppositories currently account for more than 50% of the market, while our nasal spray represents approximately 15%.
     Our extensive marketing and sales program has contributed to this dominating presence throughout Europe and Asia. Sagmel now maintains offices in 7 different countries and employs a team of more than 400 highly trained professional salespersons. Furthermore, we advertise aggressively in all major media, including newsprint, radio, television, point-of-sale vehicles, and through doctor and pharmacist education.

Distribution

     Sagmel is a recognized expert in worldwide distribution. Our company uses a sophisticated distribution network spanning 12 countries, with large centers placed at strategic locations. A proprietary computerized system for inventory management and forecasting allows for accurate, efficient distribution throughout our markets. To speed delivery, Sagmel works closely with all local and federal authorities in its respective markets, ensuring strict adherence to regulations.